Vicenç Ruiz de Porras

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Locally Advanced

Radical Prostatectomy

Top Venues

International journal of molecular sciences

Phytotherapy research : PTR

This page only lists publications with an associated author ORCID identifier.

Publications

Christine Meyer, Aranka Brockmueller, Vicenç Ruiz de Porras, Mehdi Shakibaei
Microbiota and Resveratrol: How Are They Linked to Osteoporosis? Cells 13 (13) (2024)
Christine Meyer, Aranka Brockmueller, Vicenç Ruiz de Porras, Mehdi Shakibaei
Microbiota and Resveratrol: How Are They Linked to Osteoporosis? Cells 13 (13) (2024)
Aranka Brockmueller, Vicenç Ruiz de Porras, Mehdi Shakibaei
Curcumin and its anti-colorectal cancer potential: From mechanisms of action to autophagy. Phytotherapy research : PTR (2024)
Aranka Brockmueller, Vicenç Ruiz de Porras, Mehdi Shakibaei
Curcumin and its anti-colorectal cancer potential: From mechanisms of action to autophagy. Phytotherapy research : PTR 38 (7) (2024)
Vicenç Ruiz de Porras, Albert Font
Molecular Mechanisms of Tumor Progression and New Therapeutic Strategies for Urological Cancers. International journal of molecular sciences 24 (21) (2023)
Laura Layos, Eva Martínez-Balibrea, Vicenç Ruiz de Porras
Curcumin: A Novel Way to Improve Quality of Life for Colorectal Cancer Patients? International journal of molecular sciences 23 (22) (2022)
Juan Carlos Pardo, Tamara Sanhueza, Vicenç Ruiz de Porras, Olatz Etxaniz, Helena Rodriguez, Anna Martinez-Cardús, Enrique Grande, Daniel Castellano, Miquel A Climent, Tania Lobato, Lidia Estudillo, Mireia Jordà, Cristina Carrato, Albert Font
Prognostic Impact of CD36 Immunohistochemical Expression in Patients with Muscle-Invasive Bladder Cancer Treated with Cystectomy and Adjuvant Chemotherapy. Journal of clinical medicine 11 (3) (2022)
Clara Martori, Lidia Sanchez-Moral, Tony Paul, Juan Carlos Pardo, Albert Font, Vicenç Ruiz de Porras, Maria Rosa Sarrias
Macrophages as a Therapeutic Target in Metastatic Prostate Cancer: A Way to Overcome Immunotherapy Resistance? Cancers 14 (2) (2022)
Juan C Pardo, Vicenç Ruiz de Porras, Joan Gil, Albert Font, Manel Puig-Domingo, Mireia Jordà
Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer. Nutrients 14 (4) (2022)
Vicenç Ruiz de Porras, Juan Carlos Pardo, Lucia Notario, Olatz Etxaniz, Albert Font
Immune Checkpoint Inhibitors: A Promising Treatment Option for Metastatic Castration-Resistant Prostate Cancer? International journal of molecular sciences 22 (9) (2021)
Albert Font, Vicenç Ruiz de Porras, Begoña P Valderrama, Jose Luis Ramirez, Lara Nonell, José Antonio Virizuela, Urbano Anido, Aránzazu González-Del-Alba, Nuria Lainez, Maria Del Mar Llorente, Natalia Jiménez, Begona Mellado, Jesus García-Donas, Joaquim Bellmunt
Epithelial-to-Mesenchymal Transition Mediates Resistance to Maintenance Therapy with Vinflunine in Advanced Urothelial Cell Carcinoma. Cancers 13 (24) (2021)